-
IAmBiotech: Coming soon at
#BIOCEO20: Speaker Dr. Benjamin Cowen, of ImmunoMet, a clinical-stage#biotech company developing anti-tumor and immune-metabolism therapies. Here's an early look:https://buff.ly/380SX1Z -
Coming soon at
#BIOCEO20: Speaker Dr. Benjamin Cowen, of ImmunoMet, a clinical-stage#biotech company developing anti-tumor and immune-metabolism therapies. Here's an early look: https://buff.ly/380SX1Z -
Learn the 10 most common false assumptions made during biopharma partnering deals from expert business development consultant, Linda Pullan, PhD of
@PullanConsult. Read the blog >> http://bit.ly/2S5dm0l |#partnering#biopharma#blog#biotech#pharma#BIOCEO20 pic.twitter.com/aesCdaVR4p
-
Make sure to catch fireside chats from Barbara Dalton of
@pfizer and other key biotech and pharma leaders, including@EvanLohMD,@ParatekPharma; Ted W. Love,@GBT_news; Michael M. Morrissey,@ExelixisInc and Carol Lynch,@Sandoz_Global at#BIOCEO20! View the complete program
pic.twitter.com/pVgxsC6mTB
-
ROTH Capital Partners to Sponsor & Speak at BIO CEO Conference | Business Wire https://www.businesswire.com/news/home/20200205005239/en/ROTH-Capital-Partners-Sponsor-Speak-BIO-CEO#.Xjs1iNjL77A.twitter …
#BIOCEO20 -
What's next in fighting solid tumors? Dr. Benjamin Cowen, CEO of
@ImmunoMet, a clinical stage biotech company developing anti-tumor and immune-metabolism therapies, will speak about that and his impressive experience in biotech at#BIOCEO20. https://www.bio.org/blogs/meet-immunomets-dr-benjamin-cowen-speaker-bioceo20 … -
See who you can meet at
#BIOCEO20, the must-attend meeting for top investment firms in the region! More than 340 investors have already registered, including@CanaccorGenuity,@jpmorgan and@pappas_capital.pic.twitter.com/psXb2DtcIq
-
Thank you
@NYCEDC for providing scholarships to NYC’s innovative biotechs to attend#BIOCEO20 and pitch investors. See you next week! http://bit.ly/2vL49Bo pic.twitter.com/TGQVHJeOK3
-
We look forward to seeing you in
#NYC next week!@AiCure is a proud sponsor of the BIO CEO & Investor Conference Feb. 10-11@IAmBiotech#biopharma#pharma#biotech#investors#BIOCEO20 -
IAmBiotech: Meet ImmunoMet’s Dr. Benjamin Cowen, Speaker at
#BIOCEO20 https://buff.ly/3b1VSt0 -
Meet ImmunoMet’s Dr. Benjamin Cowen, Speaker at
#BIOCEO20 https://buff.ly/3b1VSt0 -
PANEL SPOTLIGHT
Catch the Market Performance and IPO Class of 2020 panel at #BIOCEO20 and examine whether the overall market will experience a cooling off period in 2020 or if we are at the beginning of a long-term growth cycle. View the complete program
pic.twitter.com/xMTSMDwYuv
-
Our COO/CBO Stephan Lensky is presenting at the BIO CEO & Investor Conference taking place February 10-11 in
#NYC. Schedule a meeting with us to learn more.#BIOCEO20 https://bit.ly/2Oo1p3q pic.twitter.com/osXVHFeX6w
-
Last chance to register to
#BIOCEO20 organized by@IAmBiotech next week! https://www.bio.org/events/bio-ceo-investor-conference …pic.twitter.com/DeeilDDCjQ
-
We’re busy this month! Don’t miss presentations from our CEO,
@ZacharyHornby, at@IAmBiotech’s#BIOCEO20 and our CTO, Jason Christiansen, at@mnmconferences’ Biomarker and Companion Diagnostics Conference. Details here:https://boundlessbio.com/whats-new -
The Syneos One team at Syneos Health is dedicated to delivering fully integrated solutions focused on cost, speed, and risk mitigation to increase an asset’s NPV. Schedule a meeting with us at
#BIOCEO20 to learn more. pic.twitter.com/d4yny1Iydt
-
We're presenting at
#BIOCEO20 on Monday at 2:15pm EST. Listen to the webcast via the link in our investors section of our website. http://bit.ly/2u9fuep -
Meet our CEO, Florence Séjourné, at the BIO CEO & Investor Conference taking place in New York on Feb 10-11, to hear about DAV132 Phase 2 results! https://davolterra.com/2020/02/03/da-volterras-ceo-florence-sejourne-is-attending-bio-ceo-in-new-york-on-feb-10-11-2020/ …
#BIOCEO20 https://www.bio.org/events/bio-ceo-investor-conference …pic.twitter.com/Vpl9xWPjvk
-
Syneos Health provides capital solutions for biotechs by connecting innovators with the ‘right’ capital sources, and works with both to maximize ROI in a strategic ‘end to end’ model. Schedule a meeting with the Syneos team at
#BIOCEO20 to learn more. http://bit.ly/syneosheath -
The Syneos One team at Syneos Health optimizes product development, thus creating the potential for cost efficiencies, increased speed to market, and de-risking of investment dollars. Meet us at
#BIOCEO20 and learn more. http://bit.ly/syneosheath
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.